Nordic BioSite Group to Acquire LubioScience

On September 11, 2023, Nordic BioSite Group, a portfolio company of Adelis Equity Partners, announced that it has acquired LubioScience GmbH, the fastest growing life science distributor in Switzerland. This acquisition is an important step towards Nordic BioSite Group's ambition to provide exceptional distribution services across Europe.

Lenz & Staehelin advised Nordic BioSite Group in this acquisition. The Lenz & Staehelin team was led by Stephan Erni (M&A) and included Nick Mezger and Alina Kuster (both M&A), Franziska Stadtherr (Tax), and Helin Dalla Palma (Employment, Pension).